Capstan Therapeutics Funding & Investors
Capstan Therapeutics is advancing precision in vivo cell engineering to develop therapeutics for a broad range of disease categories with unmet or underserved clinical need.
capstantx.comTotal Amount Raised: $340,000,000
Capstan Therapeutics Funding Rounds
Series B
$175,000,000
Series B Investors
Ra Capital ManagementForbionAlexandria Venture InvestmentsOrbiMed AdvisorsVida VenturesNovartis Venture FundPfizer Venture InvestmentsLeaps by BayerPerceptive AdvisorsSofinnovaJohnson & Johnson Innovation – JJDCPolaris PartnersEli Lilly and Company FoundationMubadala Capital VenturesBristol-Myers SquibbSeries A
$102,000,000
Series A Investors
Pfizer Venture InvestmentsLeaps by BayerNovartis Venture FundOrbiMed AdvisorsEli Lilly and Company FoundationBristol-Myers SquibbVida VenturesAlexandria Venture InvestmentsRa Capital ManagementPolaris PartnersSeed
$63,000,000
Seed Investors
Novartis Venture FundOrbiMed AdvisorsVida VenturesRa Capital Management
Funding info provided by Diffbot.